Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03827473
Title Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer (ACADEMIC)
Acronym ACADEMIC
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.